Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
30 participants
INTERVENTIONAL
2009-06-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in Melasma
NCT05887219
Azelaic Acid 20% vs Hydroquinone 4% in Epidermal Melasma
NCT07327983
Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream in the Treatment of Melasma
NCT00848458
Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma
NCT02095990
Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma
NCT02977507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Azelaic Acid
azelaic acid gel
azelaic acid 15% gel twice a day for 6 months
Hydroquinone
hydroquinone cream
hydroquinone 4% cream twice a day for 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
azelaic acid gel
azelaic acid 15% gel twice a day for 6 months
hydroquinone cream
hydroquinone 4% cream twice a day for 6 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* all races
* males and females
* persons taking birth control medication, hormone replacement therapy or any other hormone altering medication may participate only if they have not started or stopped the medication within the last 3 months
Exclusion Criteria
* pregnancy, breastfeeding, a positive pregnancy test in the office or plans to become pregnant
* a known allergy or sensitivity ot azelaic acid or hydroquinone
* the use of photosensitizing medications (ex. tetracycline) within 3 months of the study.
* starting or stopping hormonal medication within 3 months
* chemical peels, microdermabrasion, or laser treatment within 6 months
* worsening or improving melasma
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Callender Center for Clinical Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Callender Center for Clinical Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valerie D Callender, MD
Role: PRINCIPAL_INVESTIGATOR
Howard University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Callender Center for Clinical Research
Mitchellville, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-01-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.